Journal for ImmunoTherapy of Cancer (Nov 2021)

504 A phase I, first-in-human clinical trial of the GDF-15 neutralizing antibody CTL-002 in subjects with advanced stage solid tumors (Acronym: GDFATHER)

  • Maria Rodriguez-Ruiz,
  • Reinhard Dummer,
  • Emiliano Calvo,
  • Miguel Sanmamed,
  • Jörg Wischhusen,
  • Egle Ramelyte,
  • Irene Moreno,
  • Elena Garralda,
  • Eugen Leo,
  • Maria-Elisabeth Goebeler,
  • Maria de Miguel,
  • Cyrus Michael Sayehli,
  • Guzman Alonso Casal,
  • Martin Schuler,
  • Tanja Gromke,
  • Ralf Bargou,
  • Maria Lostes,
  • Julia-Tatjana Maul,
  • Corinne Eggenschwiler,
  • Heike Richly,
  • Petra Fettes,
  • Kathrin Klar,
  • Christine Schuberth-Wagner,
  • Markus Haake

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.504
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.